Top Markets
#1 Black Phoenix Black Phoenix +21,375.11%
#2 Nesa Nesa +738.28%
#3 ADO Protocol ADO Protocol +95.15%
#4 Cortex Cortex +91.80%
#5 Ontology Gas Ontology Gas +89.55%
#6 Kinesis Silver Kinesis Silver +54.21%
#7 OpenEden OpenEden +34.72%
#8 Biconomy Biconomy +30.16%
#9 Magma Finance Magma Finance +25.39%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Orient Pharma Co., Ltd. Orient Pharma Co., Ltd.

Orient Pharma Co., Ltd.

4166
Rank in Stocks #18704
Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global... Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global pharmaceutical company engaged in the research, development, production, and sales of medicinal products. Its extensive pipeline addresses diverse therapeutic areas, including psychiatric disorders such as anti-psychotics and psychostimulants, neurological conditions like Parkinson's and Alzheimer's diseases, and treatments for sialorrhea, tuberculosis, and attention deficit hyperactivity disorder (ADHD). Beyond its drug portfolio, the company is also at the forefront of developing advanced drug delivery technologies, featuring multi-stage controlled release systems, transdermal patches, orally disintegrating tablets, sustained-release formulations, and microgranule technology.
Share Price
$0.77907619
Market Cap
$189.34M
Change (1 day)
0.41%
Change (1 year)
-7.35%
Country
TW
Trade Orient Pharma Co., Ltd. (4166)

Category

Healthcare
Earnings for Orient Pharma Co., Ltd. (4166)
Earnings in 2026 TTM: 0
According to Orient Pharma Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Orient Pharma Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK